GGrantIndex
← Search

PHASE IB/II REPETITIVE DOSE TRIAL OF GADOLINIUM TEXAPHYRIN (PCI-0120)

$207,266M01FY2000RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →